Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03778957
Brief Title: A Global Study to Evaluate Transarterial Chemoembolization (TACE) in Combination With Durvalumab and Bevacizumab Therapy in Patients With Locoregional Hepatocellular Carcinoma (EMERALD-1)

First Submitted : November 28, 2018
First Submitted that Met QC Criteria : December 17, 2018
First Posted : December 19, 2018

Last Update Submitted that Met QC Criteria : February 6, 2020
Last Update Posted : February 7, 2020